Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

NCT03645226 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03645226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03645226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
May 6, 2018
Completion date
March 29, 2023
Enrollment
441 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rem sleep behavior disorder